Potent and selective COX-2 inhibitors described in recent patent literature by Novartis April 23, 1999
FASEB presentation for PD-159879, an MMP inhibitor with potent antiinflammatory activity April 21, 1999
Phosphodiesterase inhibition contributes to the antiinflammatory activity of darbufelone April 19, 1999
RSS